PL2928861T3 - Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki - Google Patents

Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki

Info

Publication number
PL2928861T3
PL2928861T3 PL13811402T PL13811402T PL2928861T3 PL 2928861 T3 PL2928861 T3 PL 2928861T3 PL 13811402 T PL13811402 T PL 13811402T PL 13811402 T PL13811402 T PL 13811402T PL 2928861 T3 PL2928861 T3 PL 2928861T3
Authority
PL
Poland
Prior art keywords
drugs
preparing same
aminocyclobutane
derivatives
aminocyclobutane derivatives
Prior art date
Application number
PL13811402T
Other languages
English (en)
Inventor
Bernard Vacher
Elodie Blanc
Ronan Depoortere
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of PL2928861T3 publication Critical patent/PL2928861T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/14Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13811402T 2012-12-04 2013-12-04 Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki PL2928861T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1261621A FR2998892B1 (fr) 2012-12-04 2012-12-04 Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
EP13811402.0A EP2928861B1 (fr) 2012-12-04 2013-12-04 Dérivés d'aminocyclobutane, leur procédé de préparation et leur utilisation à titre de médicaments

Publications (1)

Publication Number Publication Date
PL2928861T3 true PL2928861T3 (pl) 2017-08-31

Family

ID=48128432

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13811402T PL2928861T3 (pl) 2012-12-04 2013-12-04 Pochodne aminocyklobutanu, sposób ich wytwarzania i ich zastosowanie jako leki

Country Status (31)

Country Link
US (2) US9469601B2 (pl)
EP (1) EP2928861B1 (pl)
JP (1) JP6391586B2 (pl)
KR (1) KR102221928B1 (pl)
CN (2) CN106957285B (pl)
AR (1) AR093787A1 (pl)
AU (1) AU2013354133B2 (pl)
BR (1) BR112015012752B1 (pl)
CA (1) CA2893216C (pl)
CY (1) CY1118841T1 (pl)
DK (1) DK2928861T3 (pl)
ES (1) ES2621896T3 (pl)
FR (1) FR2998892B1 (pl)
HK (1) HK1212968A1 (pl)
HR (1) HRP20170564T1 (pl)
IL (1) IL239146A (pl)
LT (1) LT2928861T (pl)
MA (1) MA38229B1 (pl)
MX (1) MX364556B (pl)
MY (1) MY179886A (pl)
NZ (1) NZ709572A (pl)
PL (1) PL2928861T3 (pl)
PT (1) PT2928861T (pl)
RS (1) RS55916B1 (pl)
RU (1) RU2655919C2 (pl)
SA (1) SA515360518B1 (pl)
SI (1) SI2928861T1 (pl)
TN (1) TN2015000240A1 (pl)
TW (1) TWI603947B (pl)
UA (1) UA114017C2 (pl)
WO (1) WO2014086825A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3774800A1 (en) 2018-03-28 2021-02-17 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途
CN114269747B (zh) * 2019-11-18 2023-04-18 苏州恩华生物医药科技有限公司 一种1’,2’-二氢-3’h-螺[环丁烷1,4’-异喹啉]-3’-酮衍生物及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133924A (en) * 1960-05-31 1964-05-19 Bristol Myers Co Amino-substituted cyclobutane carboxamides
FR2581059B1 (fr) * 1985-04-25 1988-04-22 Pf Medicament Procede de preparation du chlorhydrate de phenyl-1 diethyl amino carbonyl-1 aminomethyl-2 cyclopropane (z)
EP0747348A4 (en) * 1994-02-22 1999-07-07 Asahi Chemical Ind AMINOALKYLCYCLOPROPAN DERIVATIVES
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
CA2264182A1 (en) 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
US6593368B2 (en) 1997-09-08 2003-07-15 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
US6118017A (en) 1998-04-14 2000-09-12 Smithkline Beecham Corporation Substituted-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanocyclobutan-1-one
DE69933874T2 (de) 1998-07-16 2007-10-04 Memorial Sloan-Kettering Institute For Cancer Research Topische zusammensetzung enthaltend ein opioid-analgetika und einen nmda-antagonist
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
JP2005518411A (ja) 2002-01-16 2005-06-23 エンド ファーマシューティカルズ インコーポレーテッド 中枢神経系の障害を治療する製薬組成物及び方法
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
US7687080B2 (en) 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
JP2008528587A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
AU2008209697B2 (en) 2007-02-01 2014-02-20 Janssen Sciences Ireland Uc Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
US7638651B2 (en) * 2007-04-26 2009-12-29 Auspex Pharmaceuticals Substituted cyclohexanones
WO2009029618A1 (en) 2007-08-27 2009-03-05 Wyeth Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
PT2221296E (pt) 2007-11-28 2012-11-23 Astellas Pharma Inc Composto de indano fundido
US8722714B2 (en) 2008-01-16 2014-05-13 The Honk Kong University of Science and Technology Oxazolidine derivatives as NMDA antagonists
CA2738468A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
TW201026667A (en) 2008-09-30 2010-07-16 Merz Pharma Gmbh & Co Kgaa Glycine b antagonists
FR2943666B1 (fr) 2009-03-31 2011-04-15 Commissariat Energie Atomique Metallophore derive de nicotianamine et ses procedes de fabrication
FR2944011B1 (fr) * 2009-04-03 2011-05-20 Pf Medicament Derives d'aminocyclobutane ou d'aminocyclobutene, leur procede de preparation et leur utilisation a titre de medicaments.
NZ595759A (en) * 2009-05-07 2014-03-28 Gruenenthal Chemie Substituted phenylureas and phenylamides as vanilloid receptor ligands
FR2946535B1 (fr) 2009-06-10 2011-09-09 Neureva Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.
TWI544923B (zh) 2009-12-29 2016-08-11 何應瑞 用於治療神經退化性疾病之醫藥組合物

Also Published As

Publication number Publication date
KR102221928B1 (ko) 2021-03-02
US9469601B2 (en) 2016-10-18
HK1212968A1 (zh) 2016-06-24
RS55916B1 (sr) 2017-09-29
BR112015012752B1 (pt) 2020-10-27
MY179886A (en) 2020-11-18
JP2016502555A (ja) 2016-01-28
RU2655919C2 (ru) 2018-05-30
WO2014086825A1 (fr) 2014-06-12
EP2928861B1 (fr) 2017-01-11
EP2928861A1 (fr) 2015-10-14
AU2013354133A1 (en) 2015-07-23
SI2928861T1 (sl) 2017-05-31
FR2998892B1 (fr) 2015-01-02
US9687459B2 (en) 2017-06-27
AU2013354133B2 (en) 2017-07-06
AR093787A1 (es) 2015-06-24
UA114017C2 (xx) 2017-04-10
JP6391586B2 (ja) 2018-09-19
PT2928861T (pt) 2017-04-24
CN104854083A (zh) 2015-08-19
FR2998892A1 (fr) 2014-06-06
CA2893216C (fr) 2021-01-26
IL239146A (en) 2017-06-29
IL239146A0 (en) 2015-07-30
MA38229B1 (fr) 2016-09-30
RU2015126104A (ru) 2017-01-10
BR112015012752A2 (pt) 2017-07-11
MX364556B (es) 2019-04-30
HRP20170564T1 (hr) 2017-06-16
MX2015006686A (es) 2015-08-10
DK2928861T3 (en) 2017-04-24
SA515360518B1 (ar) 2017-05-17
TW201427930A (zh) 2014-07-16
US20170065543A1 (en) 2017-03-09
CN104854083B (zh) 2017-05-24
TN2015000240A1 (fr) 2016-10-03
KR20150091163A (ko) 2015-08-07
CA2893216A1 (fr) 2014-06-12
CN106957285A (zh) 2017-07-18
CN106957285B (zh) 2019-05-03
CY1118841T1 (el) 2018-01-10
US20150315132A1 (en) 2015-11-05
LT2928861T (lt) 2017-04-25
MA38229A1 (fr) 2016-01-29
ES2621896T3 (es) 2017-07-05
NZ709572A (en) 2019-02-22
TWI603947B (zh) 2017-11-01

Similar Documents

Publication Publication Date Title
HK1203507A1 (en) New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
ZA201404625B (en) Polycyclic derivatives, preparation method and medical uses thereof
HK1248214A1 (zh) 新噻吩並嘧啶衍生物、其製備方法及其治療用途
IL245101B (en) Derivatives of 1,4-cyclohexylamine and processes for their preparation
EP2881395A4 (en) PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT
EP2742020A4 (en) N1-CYCLIC AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
HK1211849A1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
EP2813495A4 (en) 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF
EP2837627A4 (en) AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP2865666A4 (en) HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE
EP2805954A4 (en) 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE AND MANUFACTURING METHOD AND USE THEREOF
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
EP2805956A4 (en) GAMBOGIC ACID DERIVATIVES, PREPARATION METHOD AND APPLICATION THEREOF
EP3078659A4 (en) 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
HK1212968A1 (zh) 氨基環丁烷衍生物、其製備方法及其用作藥物的用途
HUE050104T2 (hu) 3,5N-trihidroxi-alkánamid és származékok: eljárás ennek elõállítására és ennek felhasználása
IL227544A0 (en) Leoplomide and its enantiomers, a method for their preparation and medical uses thereof
AP3759A (en) Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same
EP2889292A4 (en) 2-SUBSTITUTED 2H-1,2,3-TRIAZOLE DERIVATIVE AND METHOD OF MANUFACTURING THEREOF
PL398021A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
PL398018A1 (pl) Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania
HUP1300393A2 (en) Quinazoline derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
PL398987A1 (pl) (Z)-6-siarczan-6,4'-dihydroksy-7-prenylo-4-metoksyauronu i sposób jego wytwarzania